Fortress Biotech, Inc. (FBIO) Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | |
| Net income · 12 months | 142.00M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | (m) | $142.00M | (m) |
| 2026-03-31 | (m) | $157.96M | (m) |
| 2025-12-31 | (m) | $6.82M | (m) |
| 2025-09-30 | (m) | $3.99M | (m) |
| 2025-06-30 | (m) | $-14.73M | (m) |
| 2025-03-31 | (m) | $-41.16M | (m) |
| 2024-12-31 | (m) | $-46.00M | (m) |
| 2024-09-30 | (m) | $-48.51M | (m) |
| 2024-06-30 | (m) | $-40.69M | (m) |
| 2024-03-31 | (m) | $-54.52M | (m) |
| 2023-12-31 | (m) | $-60.64M | (m) |
| 2023-09-30 | (m) | $-78.31M | (m) |
| 2023-06-30 | (m) | $-95.77M | (m) |
| 2023-03-31 | (m) | $-92.35M | (m) |
| 2022-12-31 | (m) | $-86.58M | (m) |
| 2022-09-30 | (m) | $-91.19M | (m) |
| 2022-06-30 | (m) | $-89.46M | (m) |
| 2022-03-31 | (m) | $-71.64M | (m) |
| 2021-12-31 | (m) | $-64.70M | (m) |
| 2021-09-30 | (m) | $-38.43M | (m) |
| 2021-06-30 | (m) | $-33.20M | (m) |
| 2021-03-31 | (m) | $-42.98M | (m) |
| 2020-12-31 | (m) | $-46.53M | (m) |
| 2020-09-30 | (m) | $-56.72M | (m) |
| 2020-06-30 | (m) | $-53.94M | (m) |
| 2020-03-31 | (m) | $-53.72M | (m) |
| 2019-12-31 | (m) | $-39.96M | (m) |
| 2019-09-30 | (m) | $-49.35M | (m) |
| 2019-06-30 | (m) | $-53.22M | (m) |
| 2019-03-31 | (m) | $-61.74M | (m) |
| 2018-12-31 | (m) | $-84.15M | (m) |
| 2018-09-30 | (m) | $-69.68M | (m) |
| 2018-06-30 | (m) | $-80.16M | (m) |
| 2018-03-31 | (m) | $-75.91M | (m) |
| 2017-12-31 | (m) | $-66.88M | (m) |
| 2017-09-30 | (m) | $-73.89M | (m) |
| 2017-06-30 | (m) | $-59.76M | (m) |
| 2017-03-31 | (m) | $-54.87M | (m) |
| 2016-12-31 | (m) | $-55.09M | (m) |
| 2016-09-30 | (m) | $-49.70M | (m) |
| 2016-06-30 | (m) | $-54.88M | (m) |
| 2016-03-31 | (m) | $-48.58M | (m) |
| 2015-12-31 | (m) | $-48.43M | (m) |
| 2015-09-30 | (m) | $-40.10M | (m) |
| 2015-06-30 | (m) | $-26.54M | (m) |
| 2015-03-31 | (m) | $-25.07M | (m) |
| 2014-12-31 | (m) | $-20.39M | (m) |
| 2014-09-30 | (m) | $-26.47M | (m) |
| 2014-06-30 | (m) | $-29.71M | (m) |
| 2014-03-31 | (m) | $-35.67M | (m) |
| 2013-12-31 | (m) | $-37.16M | (m) |
| 2013-09-30 | (m) | $-36.02M | (m) |
| 2013-06-30 | (m) | $-34.13M | (m) |
| 2013-03-31 | (m) | $-29.91M | (m) |
| 2012-12-31 | (m) | $-27.61M | (m) |
| 2012-09-30 | (m) | $-25.66M | (m) |
| 2012-06-30 | (m) | $-23.09M | (m) |
| 2012-03-31 | (m) | $-20.37M | (m) |
| 2011-12-31 | (m) | $-36.36M | (m) |
| 2011-09-30 | (m) | $-31.27M | (m) |
| 2011-06-30 | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) |
| 2010-12-31 | (m) | $-9.98M | (m) |
| 2010-09-30 | (m) | (m) | (m) |
| 2009-12-31 | (m) | $-3.67M | (m) |
| 2008-12-31 | (m) | $-3.80M | (m) |
| 2007-12-31 | (m) | $-2.65M | (m) |
| 2006-12-31 | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |